Content about Neurology

January 24, 2014

People with higher levels of the omega-3 fatty acids found in fish oil also may have larger brain volumes in old age equivalent to preserving one to two years of brain health, according to a study published in the Jan. 22 online issue of Neurology, the medical journal of the American Academy of Neurology.

January 17, 2014

The Consumer Healthcare Products Association responded to the Food and Drug Administration’s recommendation to discontinue prescribing and dispensing prescription combination medicines that contain more than 325 mg of acetaminophen per dosage unit, suggesting it would not impact use of over-the-counter formulations containing acetaminophen.

November 21, 2013

Teva has introduced a generic version of a drug used to treat attention deficit hyperactivity disorder, the company said Thursday.

November 18, 2013

Generic drug maker Mylan has launched its version of a drug for treating attention deficit hyperactivity disorder, the company said Monday.

November 13, 2013

As cold and flu season kicks into high gear, the Acetaminophen Awareness Coalition on Tuesday issued a nationwide safety message urging consumers to double-check their medicine labels so they don’t double-up on medicines that contain acetaminophen when treating winter illnesses.

August 26, 2013

Pfizer Consumer Healthcare on Monday introduced Advil Film Coated tablets featuring a new, fast-dissolving technology, along with a specially formulated ultra-thin coating, that speeds the ibuprofen mode of action.

August 1, 2013

Walgreens opened a new training facility here in partnership with Have Dreams, an advocacy group for children with autism, according to a story published Wednesday by Evanston Now.

The training involves setting up displays, working the cash register, stocking and organizing shelves and other skill sets that enable the autistic students to make a contribution to a store’s operations.

March 8, 2013

With private label across analgesics up an estimated 11.3% to $1.7 billion, retailers are going to need to make some tough decisions as two internal analgesic powerhouses — McNeil's Tylenol and Novartis' Excedrin — make their way back onto market after respective recalls.

January 15, 2013

CVS/pharmacy has decided to stock Tylenol pain reliever in only half of its stores, according to a Reuters report published Monday.

October 5, 2012

AccuDial Pharmaceutical earlier this year introduced five SKUs across its Children’s AccuDial Acetaminophen Oral Suspension, featuring one of the only weight-based dosing acetaminophen products with an interactive, rotating label.

September 14, 2012

The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

September 4, 2012

Bayer HealthCare's Consumer Care Division on Tuesday introduced Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms like nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity) through a formulation of aspirin, acetaminophen and caffeine.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

August 14, 2012

Upsher-Smith Labs has finalized its purchase of a British company that makes drugs for central nervous system and inflammatory disorders, the former said Tuesday.

July 23, 2012

A drug made by Pfizer for treating pain disorders doesn't affect men's reproductive functions, according to a new post-approval clinical study.

July 5, 2012

The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

June 25, 2012

The Food and Drug Administration has approved a generic drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Monday.

June 13, 2012

Merck on Wednesday released new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia.

June 7, 2012

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and XenoPort for treating pain associated with shingles.

May 29, 2012

Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

May 15, 2012

Summer Soles on Monday announced the launch of five additions to its collection of Softness of Suede insoles that help women keep their feet feeling dry and comfortable during the summer months.

April 25, 2012

Drug maker Upsher-Smith Labs will unveil updates to its educational website for healthcare providers who specialize in epilepsy at the American Academy of Neurology's annual meeting in New Orleans, the company said.

April 12, 2012

Generic drug maker Impax Labs is challenging the patent protection on a drug used to treat postherpetic neuralgia, the company said Thursday.

April 9, 2012

Idaho on Monday became state No. 21 to adopt the real-time, stop-sale technology National Precursor Log Exchange in its battle against the diversion of the cough-cold ingredient pseudoephedrine to methamphetamine.

© 2014 Drug Store News. All Rights Reserved.